Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,514,771
-$2,378,734 QoQ
Shares Held
265,284
-62.3% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 216 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Derivatives in ANNX
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$98,000
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ANNX ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ANNX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,514,771 | 265,284 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,893,505 | 702,799 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,252,029 | 1,046,221 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $481,953 | 81,411 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $98,000 | 20,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $451,216 | 92,085 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,719,251 | 379,254 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $104,473 | 27,136 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $405,891 | 78,509 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $296,794 | 48,025 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $144,489 | 38,326 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $446,024 | 163,379 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||